News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
145,209 Results
Type
Article (14322)
Company Profile (13)
Press Release (130874)
Section
Business (39791)
Career Advice (209)
Deals (5371)
Drug Delivery (16)
Drug Development (18639)
Employer Resources (25)
FDA (2885)
Job Trends (3199)
News (66035)
Policy (5356)
Tag
Academia (1693)
Alliances (12599)
Alzheimer's disease (452)
Approvals (2883)
Artificial intelligence (39)
Bankruptcy (32)
Best Places to Work (2734)
Breast cancer (50)
Cancer (412)
Cardiovascular disease (23)
Career advice (193)
CAR-T (26)
Cell therapy (73)
Clinical research (14168)
Collaboration (131)
COVID-19 (1031)
C-suite (27)
Cystic fibrosis (20)
Data (317)
Diagnostics (1573)
Drug discovery (20)
Earnings (8874)
Employer resources (20)
Events (18455)
Executive appointments (87)
FDA (3023)
Funding (166)
Gene therapy (52)
GLP-1 (97)
Government (1137)
Healthcare (4845)
Infectious disease (1058)
Inflammatory bowel disease (28)
Interviews (20)
IPO (2718)
Job creations (551)
Job search strategy (184)
Layoffs (42)
Legal (927)
Lung cancer (64)
Lymphoma (28)
Manufacturing (39)
Medical device (2397)
Medtech (2397)
Mergers & acquisitions (2725)
Metabolic disorders (41)
Neuroscience (516)
NextGen Class of 2024 (1611)
Non-profit (1867)
Northern California (320)
Opinion (45)
People (15074)
Phase I (4785)
Phase II (6515)
Phase III (4301)
Pipeline (100)
Policy (34)
Postmarket research (567)
Preclinical (2192)
Radiopharmaceuticals (45)
Rare diseases (52)
Real estate (1208)
Regulatory (3586)
Research institute (1857)
Series A (25)
Southern California (271)
Startups (1064)
United States (3057)
Vaccines (184)
Date
Today (1)
Last 7 days (65)
Last 30 days (450)
Last 365 days (7240)
2024 (7225)
2023 (8735)
2022 (11600)
2021 (12973)
2020 (12258)
2019 (10993)
2018 (8146)
2017 (7445)
2016 (7485)
2015 (8761)
2014 (6510)
2013 (5385)
2012 (5476)
2011 (5675)
2010 (4874)
Location
Africa (191)
Alabama (23)
Arizona (39)
Asia (9130)
Australia (2028)
California (696)
Canada (254)
China (48)
Colorado (38)
Connecticut (35)
Delaware (20)
Europe (19283)
Florida (135)
Illinois (97)
Indiana (35)
Japan (21)
Kansas (20)
Maryland (112)
Massachusetts (519)
Minnesota (54)
New Jersey (304)
New York (241)
North Carolina (130)
Northern California (320)
Ohio (36)
Pennsylvania (152)
South America (262)
Southern California (271)
Texas (157)
Washington D.C. (22)
Washington State (95)
145,209 Results for "institut pasteur".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology
May 29, 2024
·
3 min read
Sensorion Announces Partnership With the Institut Pasteur to Accelerate Gene Therapy Programs Targeting Hearing Disorders Has Been Extended for Five Years
Sensorion announces that the research partnership framework agreement signed in 2019 with the Institut Pasteur granting Sensorion an option for exclusive licenses to develop and market gene therapy drug candidates from collaborative projects to address unmet medical needs in the hearing field has been extended for a period of five years.
January 5, 2024
·
8 min read
Galectin Therapeutics to Present Data on Liver Cirrhosis at the 9th Edition of the Paris NASH meeting, at Institut Pasteur, September 7th & 8th 2023
Galectin Therapeutics Inc. (NASDAQ: GALT) announced today the Company will participate in the 9th Edition of the Paris NASH meeting, where a select group of international experts gather each year at the prestigious Institut Pasteur in Paris to discuss the latest scientific and clinical research developments in non-alcoholic steatohepatitis (NASH) and its complications, including liver cirrhosis.
September 7, 2023
·
5 min read
Standigm and Institut Pasteur Korea Identify Drug Candidates for Resistant Tuberculosis Thanks to Right Foundation Grant
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, and Korean non profit research institute Institut Pasteur Korea announced that they have jointly developed new lead compounds effective in treating resistant tuberculosis (TB).
April 4, 2023
·
5 min read
Business
Satio and Institut Pasteur de Dakar Form Strategic Partnership on Research, Development, Manufacture, and Distribution of Next Generation Healthcare Technologies
Satio, Inc today announced a strategic partnership agreement with Institut Pasteur de Dakar.
August 23, 2022
·
2 min read
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
BioForest
Pacific Northwest Research Institute Uncovers Hidden DNA Mechanisms of Rare Genetic Diseases
Researchers at the Pacific Northwest Research Institute (PNRI) and collaborating institutions have made a groundbreaking discovery that could significantly advance our understanding of genomic disorders.
June 21, 2024
·
3 min read
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Press Releases
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies
November 21, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
November 11, 2024
·
3 min read
1 of 14,521
Next